Table 3

Steroids, antibiotic and antifungals intake [n (%)] by diagnostic category
Total Colonised Aspergillosis
Probable Proven Probable + Proven
No. patients 245 106 125 14 139
Steroids intake before admission 101 (41.2) 29 (27.4) 64 (51.2)a 8 (57.1)a 72 (51.8)a
≥20 mg/day 59 (58.4) 15 (51.7) 40 (62.5) 4 (50.0) 44 (61.1)
Accumulated dose >100 mg 76 (75.2) 17 (58.6) 52 (81.3)a 7 (87.5) 59 (81.9)a
Accumulated dose >700 mg 20 (19.8) 6 (20.7) 11 (17.2) 3 (37.5) 14 (19.4)
Antibiotic treatment before admission 88 (35.9) 34 (32.1) 47 (37.6) 7 (50.0) 54 (38.8)
Antifungal treatment after culture request 141 (57.6) 31 (29.2) 96 (76.8)a 14 (100)a 110 (79.1)a
Voriconazole as monotherapy 68 (48.2) 11 (35.5) 55 (57.3) 2 (14.3) 57 (51.8)
Voriconazole + other antifungals 30 (21.3) 5 (16.1) 18 (18.8) 7 (50.0) 25 (22.7)
Total patients receiving voriconazole 98 (69.5) 16 (51.6) 73 (76.1) 9 (64.3) 82 (74.5)
Other antifungals 43 (30.5) 15 (48.4) 23 (24.0) 5 (35.7) 28 (25.5)

ap ≤ 0.05 vs. colonised.

Barberan et al.

Barberan et al. BMC Infectious Diseases 2012 12:295   doi:10.1186/1471-2334-12-295

Open Data